Ipsen SA
PAR:IPN

Watchlist Manager
Ipsen SA Logo
Ipsen SA
PAR:IPN
Watchlist
Price: 121.7 EUR 0.58% Market Closed
Market Cap: 10.2B EUR

Relative Value

The Relative Value of one IPN stock under the Base Case scenario is hidden EUR. Compared to the current market price of 121.7 EUR, Ipsen SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
44
Median 3Y
2.7
Median 5Y
2.7
Industry
2.6
Forward
2.6
vs History
14
vs Industry
18
Median 3Y
18.9
Median 5Y
13.6
Industry
21.4
Forward
10.7
vs History
14
vs Industry
38
Median 3Y
9.9
Median 5Y
9.3
Industry
16.4
vs History
90
vs Industry
10
Median 3Y
19.7
Median 5Y
17.6
Industry
22.8
vs History
65
vs Industry
35
Median 3Y
2.4
Median 5Y
2.6
Industry
2.2
vs History
55
vs Industry
43
Median 3Y
2.6
Median 5Y
2.6
Industry
2.9
Forward
2.5
vs History
58
vs Industry
60
Median 3Y
3.1
Median 5Y
3.1
Industry
5.5
vs History
90
vs Industry
44
Median 3Y
7.1
Median 5Y
6.9
Industry
13
Forward
6.5
vs History
47
vs Industry
35
Median 3Y
12.6
Median 5Y
9.5
Industry
16.5
Forward
8.1
vs History
28
vs Industry
39
Median 3Y
9.4
Median 5Y
8.9
Industry
15.6
vs History
25
vs Industry
7
Median 3Y
14
Median 5Y
13.3
Industry
18.7
vs History
25
vs Industry
38
Median 3Y
1.8
Median 5Y
2
Industry
1.9

Multiples Across Competitors

IPN Competitors Multiples
Ipsen SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Ipsen SA
PAR:IPN
10.1B EUR 2.7 22.5 5.7 9.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.5B USD 5.4 19.8 16.2 21.1
CH
Roche Holding AG
SIX:ROG
268.8B CHF 4.4 28.5 12.1 14.2
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP 5.1 31.5 108.7 159.1
US
Merck & Co Inc
NYSE:MRK
277.5B USD 4.3 14.6 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.4B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.8B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
FR
Ipsen SA
PAR:IPN
Average P/E: 24.8
22.5
42%
0.5
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.6
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Ipsen SA
PAR:IPN
Average EV/EBITDA: 400.6
5.7
2%
2.8
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Ipsen SA
PAR:IPN
Average EV/EBIT: 1 713.4
9.7
19%
0.5
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5